Fontana is interviewed by Paul C
Advances in Experimental Medicine and Biology, 1307 , 171192
With excess weight being linked to a host of health risks including elevated blood sugar, impaired renal function, and even a risk of diabetes, we should be doing anything we can to reduce excess weight
However, the FDA There is an intense race among pharmaceutical companies to enter the GLP-1 medication market, especially in countries outside the United States, where patents are expiring
Eating at your destination Vacation eating presents temptations and challenges
Patients should be monitored for any exacerbation of gastrointestinal symptoms when using both medications concurrently